Disease: transplant rejection (immunosuppression for transplant recipients)

Tracing the Origin and Evolution of the Fungal Mycophenolic Acid Biosynthesis Pathway

Scientists studied how different mold species produce mycophenolic acid (MPA), a drug used to prevent transplant rejection in millions of patients worldwide. By examining the genomes of nearly 500 fungal species, they discovered which molds can make MPA and how they evolved this ability. The research found that MPA-producing fungi all have special resistance mechanisms to protect themselves from the toxic compound they produce, and these protection strategies differ between species.

Read More »
Scroll to Top